China Medical System Lim... (CHSYF)
China Medical System Statistics
Share Statistics
China Medical System has 2.42B shares outstanding. The number of shares has increased by -0.51% in one year.
| Shares Outstanding | 2.42B |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | 0.44% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 10.18 and the forward PE ratio is null. China Medical System's PEG ratio is -0.32.
| PE Ratio | 10.18 |
| Forward PE | n/a |
| PS Ratio | 2.21 |
| Forward PS | n/a |
| PB Ratio | 1.01 |
| P/FCF Ratio | 20.29 |
| PEG Ratio | -0.32 |
Enterprise Valuation
China Medical System has an Enterprise Value (EV) of 13.64B.
| EV / Sales | 1.83 |
| EV / EBITDA | 5.91 |
| EV / EBIT | 10.76 |
| EV / FCF | 16.79 |
Financial Position
The company has a current ratio of 5.74, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.74 |
| Quick Ratio | 5.24 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 1.06 |
| Interest Coverage | 44.87 |
Financial Efficiency
Return on Equity is 9.93% and Return on Invested Capital is 8%.
| Return on Equity | 9.93% |
| Return on Assets | 8.97% |
| Return on Invested Capital | 8% |
| Revenue Per Employee | $1,216,249.8 |
| Profits Per Employee | $263,766.16 |
| Employee Count | 6,141 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.66 |
Taxes
| Income Tax | 397.23M |
| Effective Tax Rate | 19.76% |
Stock Price Statistics
The stock price has increased by -0.08% in the last 52 weeks. The beta is 0.91, so China Medical System's price volatility has been higher than the market average.
| Beta | 0.91 |
| 52-Week Price Change | -0.08% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 0.93 |
| Relative Strength Index (RSI) | 0 |
| Average Volume (20 Days) | 2 |
Income Statement
In the last 12 months, China Medical System had revenue of 7.47B and earned 1.62B in profits. Earnings per share was 0.67.
| Revenue | 7.47B |
| Gross Profit | 5.42B |
| Operating Income | 1.73B |
| Net Income | 1.62B |
| EBITDA | 2.31B |
| EBIT | 2.05B |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 3.71B in cash and 860.74M in debt, giving a net cash position of 2.85B.
| Cash & Cash Equivalents | 3.71B |
| Total Debt | 860.74M |
| Net Cash | 2.85B |
| Retained Earnings | 13.96B |
| Total Assets | 18.05B |
| Working Capital | 7.19B |
Cash Flow
In the last 12 months, operating cash flow was 1.27B and capital expenditures -455.91M, giving a free cash flow of 812.64M.
| Operating Cash Flow | 1.27B |
| Capital Expenditures | -455.91M |
| Free Cash Flow | 812.64M |
| FCF Per Share | 0.33 |
Margins
Gross margin is 72.6%, with operating and profit margins of 23.2% and 21.69%.
| Gross Margin | 72.6% |
| Operating Margin | 23.2% |
| Pretax Margin | 26.92% |
| Profit Margin | 21.69% |
| EBITDA Margin | 30.9% |
| EBIT Margin | 23.2% |
| FCF Margin | 10.88% |
Dividends & Yields
CHSYF pays an annual dividend of $0.04, which amounts to a dividend yield of 2.73%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 2.73% |
| Dividend Growth (YoY) | -81.12% |
| Payout Ratio | 26.61% |
| Earnings Yield | 9.82% |
| FCF Yield | 4.93% |
Analyst Forecast
Currently there are no analyst rating for CHSYF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 4.25 |
| Piotroski F-Score | 6 |